FIELD: biotechnology.
SUBSTANCE: present invention relates to biotechnology, specifically to a nucleotide sequence comprising a gene of consensus rabies virus glycoprotein optimized for E. coli expression with SEQ ID NO: 1.
EFFECT: transformation of E.coli bacteria with a plasmid carrying the obtained gene enables efficient production of a recombinant immunoactive consensus glycoprotein.
1 cl, 1 dwg, 1 tbl, 4 ex
| Title | Year | Author | Number |
|---|---|---|---|
| GENETIC CONSTRUCT BASED ON AN OPTIMIZED GENE OF RABIES VIRUS CONSENSUS GLYCOPROTEIN FOR PREVENTING RABIES | 2018 |
|
RU2707544C1 |
| RECOMBINANT ANTIBODIES AND COMPOSITIONS, METHODS FOR PRODUCTION AND USES THEREOF | 2002 |
|
RU2292353C2 |
| GENETIC (RECOMBINANT) DNA CONSTRUCT COMPRISING CODON-OPTIMIZED GLYCOPROTEIN GENE (PROTEIN G) OF RABIES VIRUS WITH CONSENSUS AMINO ACID SEQUENCE WHICH TAKES INTO ACCOUNT THE AMINO ACID SEQUENCE OF PROTEIN G, ISOLATED FROM RABIES VIRUS STRAIN CIRCULATING IN THE RUSSIAN FEDERATION | 2015 |
|
RU2626605C2 |
| RECOMBINANT FUSION PROTEIN SPECIFICALLY BINDING AND NEUTRALIZING RABIES VIRUS, METHOD FOR PRODUCTION AND USE THEREOF | 2023 |
|
RU2829507C1 |
| HUMANISED ANTIGEN-BINDING FRAGMENTS (Fab) AGAINST RABIES VIRUS, ISOLATED DNA FRAGMENT, CODING Fab AGAINST RABIES VIRUS, YEAST CELL, TRANSFORMED BY DNA FRAGMENT, AND METHOD OF OBTAINING Fab AGAINST RABIES VIRUS WITH APPLICATION OF YEASTS | 2010 |
|
RU2440412C2 |
| PHARMACEUTICAL COMPOSITION FOR PASSIVE RABIES IMMUNIZATION, PHARMACEUTICAL KIT, PHARMACEUTICAL KIT APPLICATION METHOD | 2016 |
|
RU2661028C2 |
| TRIMERISED SINGLE-DOMAIN ANTIBODY THAT SPECIFICALLY BINDS WITH GLYCOPROTEIN G OF RABIES VIRUS, NEUTRALISING RABIES VIRUS | 2013 |
|
RU2533802C1 |
| RECOMBINANT PLASMID pET21-GST-CD WHICH ENSURES THE SYNTHESIS AND SECRETION OF Gc ECTODOMAIN OF HANTAAN VIRUS GLYCOPROTEIN, AND THE RECOMBINANT ESCHERICHIA COLI STRAIN BL21(DE3)pLysE pET21-GST-CD, A PRODUCER OF THE Gc PROTEIN, THE ECTODOMAIN OF HANTAAN VIRUS GLYCOPROTEIN | 2023 |
|
RU2807520C1 |
| MONOCLONAL ANTIBODY TO RDB FRAGMENT IN COMPOSITION OF SARS-COV-2 S PROTEIN | 2020 |
|
RU2744274C1 |
| pET21-GST-CD RECOMBINANT PLASMID WHICH ENSURES SYNTHESIS AND SECRETION OF Gn ECTODOMAIN OF HANTAAN VIRUS GLYCOPROTEIN, AND BL21(DE3)PLYSE pET21-GST-CD RECOMBINANT ESCHERICHIA COLI STRAIN, PRODUCER OF Gn PROTEIN, ECTODOMAIN OF HANTAAN VIRUS GLYCOPROTEIN | 2023 |
|
RU2809199C1 |
